BR9803755A - Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas. - Google Patents

Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas.

Info

Publication number
BR9803755A
BR9803755A BR9803755-2A BR9803755A BR9803755A BR 9803755 A BR9803755 A BR 9803755A BR 9803755 A BR9803755 A BR 9803755A BR 9803755 A BR9803755 A BR 9803755A
Authority
BR
Brazil
Prior art keywords
improved process
obtaining
correctly connected
insulin precursors
cystine bridges
Prior art date
Application number
BR9803755-2A
Other languages
English (en)
Inventor
Franz-Josef Dr Rubroeder
Reinhold Dr Keller
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Priority to BRPI9816233A priority Critical patent/BRPI9816233B8/pt
Publication of BR9803755A publication Critical patent/BR9803755A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Patente de Invenção:<B>"PROCESSO APERFEIçOADO PARA OBTENçãO DE PRECURSORES DE INSULINA TENDO PONTES DE CISTINA CORRETAMENTE LIGADAS"<D>. Processo aperfeiçoado para obtenção de precursores de insulina tendo ponte de cistina corretamente ligadas. A presente invenção refere-se a um processo aperfeiçoado para obtenção de um precursor de insulina ou derivados de insulina tendo ponte de cistina corretamente ligadas na presença de cisteína ou cloridrato de cisteína e de um auxiliar caotrópico.
BR9803755-2A 1997-08-18 1998-08-17 Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas. BR9803755A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI9816233A BRPI9816233B8 (pt) 1997-08-18 1998-08-17 processo de preparação de insulinas ou de um derivado de insulina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
BR9803755A true BR9803755A (pt) 2000-03-28

Family

ID=7839275

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI9816233A BRPI9816233B8 (pt) 1997-08-18 1998-08-17 processo de preparação de insulinas ou de um derivado de insulina
BR9803755-2A BR9803755A (pt) 1997-08-18 1998-08-17 Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI9816233A BRPI9816233B8 (pt) 1997-08-18 1998-08-17 processo de preparação de insulinas ou de um derivado de insulina

Country Status (21)

Country Link
US (3) US5986048A (pt)
EP (2) EP0980874B1 (pt)
JP (1) JP4291900B2 (pt)
KR (2) KR100537842B1 (pt)
CN (3) CN101186940B (pt)
AR (1) AR016821A1 (pt)
AT (2) ATE217012T1 (pt)
AU (1) AU744824B2 (pt)
BR (2) BRPI9816233B8 (pt)
CA (1) CA2245151C (pt)
CZ (1) CZ295679B6 (pt)
DE (3) DE19735711C2 (pt)
DK (2) DK0906918T3 (pt)
ES (2) ES2176870T3 (pt)
HK (3) HK1018464A1 (pt)
HU (2) HU228161B1 (pt)
ID (1) ID20717A (pt)
PL (1) PL191901B1 (pt)
PT (2) PT980874E (pt)
RU (2) RU2205836C2 (pt)
TR (1) TR199801587A2 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
EP1242610A1 (en) * 1999-12-22 2002-09-25 Novo Nordisk A/S Method for extractive refolding of scrambledsingle-chain polypeptides
AU2001280436A1 (en) * 2000-07-12 2002-01-21 Eli Lilly And Company Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
MY143274A (en) 2005-12-22 2011-04-15 Genentech Inc Recombinant production of heparin binding proteins
US20080125580A1 (en) 2006-07-14 2008-05-29 Genentech, Inc. Refolding of Recombinant Proteins
EP2544008A1 (en) * 2007-07-03 2013-01-09 Amgen Inc. Measurement of protein using inclusion body dry weight
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
CA2711749A1 (en) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Novel insulin derivatives having an extremely delayed time-action profile
WO2009133529A2 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Processes for refolding of insulin
RS56632B1 (sr) 2008-10-17 2018-03-30 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
AU2010317995B2 (en) 2009-11-13 2014-04-17 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
CN102711804B (zh) 2009-11-13 2015-09-16 赛诺菲-安万特德国有限公司 包含glp-1激动剂和甲硫氨酸的药物组合物
JP6199186B2 (ja) 2010-08-30 2017-09-20 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病の治療用の医薬の製造のためのａｖｅ００１０の使用
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
US20180282405A1 (en) * 2012-08-05 2018-10-04 Absci, Llc Cytoplasmic expression system
EP2931301B2 (en) 2012-12-17 2021-09-15 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
PE20191481A1 (es) * 2013-02-26 2019-10-18 Hanmi Pharm Ind Co Ltd Analogo de insulina novedoso y su uso
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
US10407483B2 (en) 2014-03-14 2019-09-10 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
MX2017007699A (es) 2014-12-12 2017-09-18 Sanofi Aventis Deutschland Formulacion de proporcion fija de insulina glargina/lixisenatida.
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
US10745457B2 (en) 2015-09-02 2020-08-18 Merck Sharp & Dohme Corp. Process for obtaining insulin with correctly formed disulfide bonds
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
WO1996020724A1 (en) * 1994-12-29 1996-07-11 Bio-Technology General Corp. Generation of human insulin
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
HK1119449A1 (en) 2009-03-06
KR19990023651A (ko) 1999-03-25
ES2176870T3 (es) 2002-12-01
US20020156234A1 (en) 2002-10-24
EP0980874A1 (de) 2000-02-23
JP4291900B2 (ja) 2009-07-08
HUP9801886A3 (en) 1999-06-28
CN1483831B (zh) 2012-06-13
EP0906918B1 (de) 2002-05-15
TR199801587A3 (tr) 1999-03-22
DE59804121D1 (de) 2002-06-20
KR100537842B1 (ko) 2006-03-23
CN1209437A (zh) 1999-03-03
HU9801886D0 (en) 1998-10-28
AU744824B2 (en) 2002-03-07
HU228203B1 (en) 2013-01-28
CZ295679B6 (cs) 2005-09-14
HK1061870A1 (en) 2004-10-08
DE59803985D1 (de) 2002-06-06
ES2177178T3 (es) 2002-12-01
BRPI9816233B1 (pt) 2016-09-27
CA2245151A1 (en) 1999-02-18
DE19735711A1 (de) 1999-02-25
US6727346B2 (en) 2004-04-27
DE19735711C2 (de) 2001-04-26
DK0906918T3 (da) 2002-09-09
JPH11130798A (ja) 1999-05-18
PT980874E (pt) 2002-10-31
US5986048A (en) 1999-11-16
HUP9801886A2 (hu) 1999-01-28
CZ259898A3 (cs) 1999-03-17
HU228161B1 (en) 2013-01-28
ATE217012T1 (de) 2002-05-15
CN101186940B (zh) 2012-02-08
AR016821A1 (es) 2001-08-01
RU2205836C2 (ru) 2003-06-10
RU2302882C2 (ru) 2007-07-20
CN101186940A (zh) 2008-05-28
BRPI9816233B8 (pt) 2021-05-25
CN1483831A (zh) 2004-03-24
CA2245151C (en) 2009-10-06
HK1018464A1 (en) 1999-12-24
PT906918E (pt) 2002-10-31
KR20050067371A (ko) 2005-07-01
ATE217636T1 (de) 2002-06-15
DK0980874T3 (da) 2002-08-19
KR100574580B1 (ko) 2006-04-28
HU0600287D0 (en) 2006-05-29
TR199801587A2 (xx) 1999-03-22
CN1132845C (zh) 2003-12-31
PL191901B1 (pl) 2006-07-31
EP0906918A2 (de) 1999-04-07
US6380355B1 (en) 2002-04-30
EP0980874B1 (de) 2002-05-02
AU8076398A (en) 1999-02-25
PL328108A1 (en) 1999-03-01
ID20717A (id) 1999-02-18
EP0906918A3 (de) 1999-08-11

Similar Documents

Publication Publication Date Title
BR9803755A (pt) Processo aperfeiçoado para obtenção de precursores de insulina tendo pontes de cistina corretamente ligadas.
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
BR9814300A (pt) Método de preparação de óxidos de tetraidrobenzotiepina enanciomericamente enriquecidos
CY1109593T1 (el) Παραγωγα 12,13-κυκλοπροπανο εποθιλονης
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
DK1214936T3 (da) Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
DE59907871D1 (de) Neue galenische zubereitungsformen von meloxicam zur oralen applikation
BR9905852A (pt) Poliuretanos termoplásticos alifáticos, processo para sua preparação e seu emprego
ATE256658T1 (de) Funktionelle vitamin-d-derivate und verfahren zur bestimmung von 25-hydroxy- und 1alpha,25- dihydroxy-vitamin-d
ID30181A (id) Asam antranilat- dan asam tioantranilat-n-aril amida
CY1112330T1 (el) Πρωτεϊνες συνδεσης gag
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
BR9712100A (pt) Intermediários e processo para preparar olanzapina.
DK0987256T3 (da) Krystalform af N-(4-trifluormethylphenyl)-5-methylisoxazol-4-carboxylsyreamid
BR0100982A (pt) Processo para a preparação de derivados deresorcinol
BR9507771A (pt) Processos para preparação de ácido 1-Butil-2-(2&#39;-(2H-Tetratozol-5-IL)-Bifenil-4-Ilmetil(-1H-Indol-3-Carboxílico
ES2143666T3 (es) P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales.
CY1105526T1 (el) Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης
BR0212772A (pt) Processo para a preparação de repaglinida
ATE408631T1 (de) Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion
BR9712773A (pt) Processo para a sìntese de benzotiofenos
BR9704653A (pt) Processo para aumentar o tempo de vida útil de componentes dentários
BR0212287A (pt) Proteìna de ligação caspase-8, sua preparação e uso
BR0110206A (pt) Inibidores de peptìdeo deformilase
BR9908199A (pt) Derivados de sulfonamida

Legal Events

Date Code Title Description
TC Change of name
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA DE ACORDO COM O ART. 8O COMBINADO COM O ART. 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]